Crossmark

Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient

Crossref DOI link: https://doi.org/10.1007/s40261-018-0691-8

Published Online: 2018-08-27

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Metro, Giulio https://orcid.org/0000-0002-4978-9212
Baglivo, Sara

Siggillino, Annamaria

Ludovini, Vienna

Chiari, Rita

Rebonato, Alberto

Bellezza, Guido
License Information

Text and Data Mining valid from 2018-08-27
More Information

Article History

First Online: 27 August 2018

Compliance with Ethical Standards

:

: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

: The authors declare that they have no competing interests.